Sintx Technologies (SINT) Capital Expenditures Growth (3y) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 1.64% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 8.49% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 10.17% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 16.83% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 1.81% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 2.15% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 0.84% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 10.35% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 8.08% |
| 10 | Sintx Technologies | 8.71 Mn | 6.82 Mn | 144,000.00 | -69.05% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -69.05% |
| Dec 31, 2025 | -47.84% |
| Sep 30, 2025 | -45.22% |
| Mar 31, 2025 | -36.46% |
| Dec 31, 2024 | -35.10% |
| Sep 30, 2024 | -83.79% |
| Jun 30, 2024 | -6.20% |
| Mar 31, 2024 | -3.06% |
| Dec 31, 2023 | -29.37% |
| Sep 30, 2023 | 18.67% |
| Jun 30, 2023 | 20.51% |
| Mar 31, 2023 | 123.99% |
| Dec 31, 2022 | 266.76% |
| Sep 30, 2022 | 59.47% |
| Dec 31, 2021 | 79.54% |
| Sep 30, 2021 | 297.96% |
| Jun 30, 2021 | 78.10% |
| Mar 31, 2021 | 77.77% |
| Dec 31, 2020 | 30.66% |
| Sep 30, 2020 | -43.70% |
| Jun 30, 2020 | -36.24% |
| Mar 31, 2020 | -58.41% |
| Dec 31, 2019 | -70.92% |
| Sep 30, 2019 | 17.84% |
| Dec 31, 2018 | -39.71% |
| Sep 30, 2018 | -21.26% |
| Jun 30, 2018 | -18.07% |
| Mar 31, 2018 | -50.30% |
| Dec 31, 2017 | -102.33% |
| Sep 30, 2017 | -14.83% |
| Jun 30, 2017 | -35.82% |
| Mar 31, 2017 | -18.93% |
| Dec 31, 2016 | -31.59% |
| Sep 30, 2016 | -53.82% |
| Jun 30, 2016 | -42.47% |
| Mar 31, 2016 | -5.82% |